These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 6523365)
1. [Possibilities for cytochemical research on neutrophils and lymphocytes in assessing the severity of the course and the completeness of recovery in viral hepatitis B]. Vasil'ev VS Ter Arkh; 1984; 56(10):79-80. PubMed ID: 6523365 [TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726 [TBL] [Abstract][Full Text] [Related]
3. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg. Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080 [No Abstract] [Full Text] [Related]
4. [Production of hepatitis B virus from peripheral blood lymphocytes stimulated with phytohemagglutinin]. Sarría L; Gallego L; de las Heras B; Basaras M; Cisterna R Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):187-9. PubMed ID: 8512969 [TBL] [Abstract][Full Text] [Related]
5. [Cytochemical parameters in studying the body at peripheral hemopoiesis level]. Bazeliuk LT; Amanbekova AU; Tusupbekova GA; Mukhametzhanova RA Med Tr Prom Ekol; 2005; (4):12-5. PubMed ID: 15921187 [TBL] [Abstract][Full Text] [Related]
6. Active rosette-forming lymphocytes in chronic hepatitis. Stanciu L; Urcan S; Părău N; Radu D; Popescu S Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551 [TBL] [Abstract][Full Text] [Related]
8. [A cytochemical study of leukocyte lipids in patients with viral hepatitis]. Nagoev BS; Tasheva DM Lab Delo; 1989; (7):38-40. PubMed ID: 2477597 [TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of erythrocyte carbohydrate metabolism indicators in chronic subclinical HBsAG carrier state]. Levina LD; Bezuglova IA; Proĭdakov MA Klin Med (Mosk); 1995; 73(6):26-8. PubMed ID: 8691773 [TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP; Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [TBL] [Abstract][Full Text] [Related]
11. Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection. Huges-Law G; de Gast GC; Houwen B; The TH; Tegzess AM; van der Hem GK Hepatogastroenterology; 1981 Apr; 28(2):93-5. PubMed ID: 7216154 [TBL] [Abstract][Full Text] [Related]
12. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing. Weber B; Mühlbacher A; Melchior W J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009 [TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E in acute viral hepatitis]. Davydov RR; Fokina AN; Zhukov VP; Davidovich GM Klin Med (Mosk); 1993; 71(3):47-9. PubMed ID: 8015218 [TBL] [Abstract][Full Text] [Related]
14. [Laser nephelometric method for determining HBsAg in the serum of patients with hepatitis]. Ivanov NR; Shub GM; Mazmanidi EG Lab Delo; 1986; (12):735-8. PubMed ID: 2434716 [No Abstract] [Full Text] [Related]
16. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen. Olde C; Garcia M J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927 [TBL] [Abstract][Full Text] [Related]
18. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria. Iwalokun BA; Hodonu SO; Olaleye BM; Olabisi OA Afr J Med Med Sci; 2006 Sep; 35(3):337-43. PubMed ID: 17312742 [TBL] [Abstract][Full Text] [Related]
20. KEMRI Hep-cell II hepatitis B surface antigen screening kit. Okoth FA; Kaiguri PM; Mathenge E; Tuei J; Muchiri S; Owino N; Kamau G; Kulundu J; Njuguna A; Tukei PM; Yano M; Naruse T East Afr Med J; 1999 Sep; 76(9):530-2. PubMed ID: 10685326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]